Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

System-IGF-1 Pathway and Alzheimer's Disease (SIGAL)

This study has been completed.
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris Identifier:
First received: March 26, 2008
Last updated: June 5, 2013
Last verified: June 2013